Personal Injury Ads: Targeting Beyond Prasad | SEO Tips

Your editorial “

Dr. Prasad, the FDA’s Grim Reaper” (Sept. 23) rightly notes that there are some regulators who “loathe drug makers more than they care about helping patients.” If they were committed to the latter, they would focus on advertisements from trial lawyers, not pharmaceutical companies.

The FDA’s Vinay prasad says that “compelling and attention-grabbing visuals” and “frequent scene changes, compete for the viewers’ attention and make it difficult for the viewers to comprehend” a drug’s risk profile. But doctors can help weigh the value of a given product before prescribing it.